|
US2020397701A1
|
|
Drug delivery system and method for the treatment of neuro-degenerative disease
|
|
US2018272307A1
|
|
Apparatus and methods for making nanosomes loaded with nucleic acid
|
|
CN107708674A
|
|
combination HIV therapy
|
|
US2015094363A1
|
|
Transplantation therapies
|
|
US2016008377A1
|
|
Formulations and compositions of vitamin d analogs for treating and preventing cancer and other diseases
|
|
US2015291616A1
|
|
Bryoid compositions, methods of making and use thereof
|
|
CN105228614A
|
|
Be used for the treatment of combined therapy agent and the method for neurodegenerative disease and Other diseases
|
|
US2014080114A1
|
|
Methods, kits and compositions for inactivation of viral agents in whole blood and red blood cell concentrates
|
|
US2013156822A1
|
|
Drug delivery system and method for the treatment of neuro-degenerative disease
|
|
US2013122106A1
|
|
Dosage form, and methods of making and using the same, to produce immunization in animals and humans
|
|
US2010166806A1
|
|
Combination therapy comprising the use of protein kinase C modulators and Histone Deacetylase inhibitors for treating HIV-1 latency
|
|
US2009288788A1
|
|
Pretreating cellulosic biomass
|
|
US2006240098A1
|
|
Formulations for hyperforin-enriched hypericum fractions
|
|
US2006269928A1
|
|
Compositions, methods and apparatus for supercritical fluid virus inactivation
|
|
US2005118282A1
|
|
Compositions and methods for inhibiting 5-alpha reductase
|
|
US2005106111A1
|
|
Compositions and methods for reducing dental plaque
|
|
US2005095283A1
|
|
Compositions and methods for topically treating diseases
|
|
US2005059641A1
|
|
Compositions and methods for treating and preventing cancer using analogs of vitamin D
|
|
US2006033224A1
|
|
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
|
|
US7037534B2
|
|
Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds
|
